We cherry-pick Israeli (or Israel-related) venture-backed bio-pharma companies across different development stages.

We’re actively looking for companies that meet the following criteria:

Cutting-edge science
State-of-the-art scientific foundations backed by strong IP protection

Backed by venture capital
Have already attracted investment from world-class investors

Significant unmet need
Indications inadequate or non-existent therapies

Strong management
Leadership by industry veterans – executives to scientists

Therapeutic pipeline
A rich pipeline to follow the lead indication

A Member firm of SBI Group, Japan

© 2020 SBI JI Innovation Advisory Ltd. All rights reserved